Insider Transactions in Q3 2021 at Athira Pharma, Inc. (ATHA)

ATHA Quotes by TradingView

Insider Transaction List (Q3 2021)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Aug 17 2021
Mark James Litton President and CEO
BUY
Exercise of conversion of derivative security
Direct
50,440 +30.51%
$50,440 $1.35 P/Share
Jul 21 2021
Hans Moebius Chief Medical Officer
BUY
Exercise of conversion of derivative security
Direct
28,372 +40.18%
$28,372 $1.35 P/Share

Track Institutional and Insider Activities on ATHA

Follow Athira Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATHA shares.

Notify only if

Insider Trading

Get notified when an Athira Pharma, Inc. insider buys or sells ATHA shares.

Notify only if

News

Receive news related to Athira Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATHA